139 related articles for article (PubMed ID: 31270053)
1. [Correlation between methylation level of
Zheng Z; Ji H; Chen C; Li Y; Duan S
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):724-730. PubMed ID: 31270053
[TBL] [Abstract][Full Text] [Related]
2. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
3. Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators.
Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Ramos KS; Alvarado-Cruz I; Quintanilla-Vega B; González-Arias CA; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 May; 26(15):15124-15135. PubMed ID: 30924039
[TBL] [Abstract][Full Text] [Related]
4. Methylation patterns of the
Paredes-Céspedes DM; Bernal-Hernández YY; Herrera-Moreno JF; Rojas-García AE; Medina-Díaz IM; González-Arias CA; Barrón-Vivanco BS
Hum Exp Toxicol; 2022; 41():9603271211063161. PubMed ID: 35067100
[TBL] [Abstract][Full Text] [Related]
5. Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.
Au WY; Fung AT; Ma ES; Chan CH; Wong KF; Chim CS; Liang RH; Kwong YL
Br J Haematol; 2005 Dec; 131(5):632-5. PubMed ID: 16351640
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
7. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours.
Rousseau E; Ruchoux MM; Scaravilli F; Chapon F; Vinchon M; De Smet C; Godfraind C; Vikkula M
Neuropathol Appl Neurobiol; 2003 Dec; 29(6):574-83. PubMed ID: 14636164
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
Cechova H; Lassuthova P; Novakova L; Belickova M; Stemberkova R; Jencik J; Stankova M; Hrabakova P; Pegova K; Zizkova H; Cermak J
Neoplasma; 2012; 59(2):168-74. PubMed ID: 22248274
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma.
Iolascon A; Giordani L; Moretti A; Tonini GP; Lo Cunsolo C; Mastropietro S; Borriello A; Ragione FD
Pediatr Res; 1998 Jan; 43(1):139-44. PubMed ID: 9432125
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
[TBL] [Abstract][Full Text] [Related]
12. [Methylation of the genes in the 9P21 region in children with acute myeloid leukemia].
Zhang L; Ruan M; Liu XM; Zhang JY; Guo Y; Yang WY; Liu F; Liu TF; Wang SC; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):6-10. PubMed ID: 25616284
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
Fu HY; Shen JZ; Wu Y; Shen SF; Zhou HR; Fan LP
Oncol Rep; 2010 Aug; 24(2):335-43. PubMed ID: 20596618
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.
Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG
Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
[TBL] [Abstract][Full Text] [Related]
16. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
17. Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma.
Hamada K; Kohno T; Kawanishi M; Ohwada S; Yokota J
Genes Chromosomes Cancer; 1998 Jul; 22(3):232-40. PubMed ID: 9624535
[TBL] [Abstract][Full Text] [Related]
18. CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients.
Zhou S; Zhang Y; Wang L; Zhang Z; Cai B; Liu K; Zhang H; Dai M; Sun L; Xu X; Cai H; Liu X; Lu G; Xu G
J Transl Med; 2016 Dec; 14(1):333. PubMed ID: 27905995
[TBL] [Abstract][Full Text] [Related]
19. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
[TBL] [Abstract][Full Text] [Related]
20. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
